There was a significant loss of tumour necrosis factor (TNF)-α, and significant increase of interleukins (IL)-9, IL-12 and IL-13 in the sera of patients with L-CTCL compared with HDs. The gene discussed is IL13; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.